Understanding the association of genetic variation with its functional consequences in proteins is essential for the interpretation of genomic data and identifying causal variants in diseases. Integration of protein function knowledge with genome annotation can assist in rapidly comprehending genetic variation within complex biological processes. Here, we describe mapping UniProtKB human sequences and positional annotations, such as active sites, binding sites, and variants to the human genome 
proteomic, and clinical communities should greatly inform studies on the functional consequences of variants. Although UniProtKB is being exploited for this purpose to a small extent, for example, PolyPhen-2 (Adzhubei, Jordan, & Sunyaev, 2013) incorporates information on protein active sites from UniProtKB, it is vastly underutilized. PolyPhen and other tools use a variety of structural and sequence conservation information to predict the effects of missense variants and have been incorporated into variant interpretation resources and commercial pipelines (Ioannidis et al., 2016; Kircher et al., 2014; McLaren et al., 2016; Nykamp et al., 2017; Qian et al., 2018; Shihab et al., 2013; Shihab et al., 2015) . While these tools work very well for some well-studied genes (e.g., BRCA1, TP53), the results are less established for many others and improvements are needed (Guidugli et al., 2018; Karbassi et al., 2016; Mahmood et al., 2017; Qian et al., 2018; Tavtigian et al., 2018) .
Genome browsers (Kent et al., 2002; Yates et al., 2016) provide an interactive graphical representation of genomic data. They utilize standard data file formats, enabling the import and integration of multiple independent studies, as well as an individual userʼs own data, through community track hubs (Raney et al., 2014) . Here, we illustrate the utility of representing UniProtKB protein functional annotations at the genomic level via track hubs and demonstrate how this information can be used in combination with genomic annotations to interpret the effect of missense variants in disease-related genes and proteins using specific biological examples and some larger scale comparisons.
Knowledge of variantʼs disease associations is also important in evaluating its impact. Many resources, including UniProtKB and ClinVar (Landrum et al., 2018) provide disease-related information on variants. In UniProtKB, the majority of this information comes from the literature, although OMIM (OMIM, 2018) is also used, primarily as a source for disease names and descriptions and as a means identifying relevant literature. ClinVar is an open database for the deposition of variants identified in clinical genome screens; the scientist submitting variant information is responsible for assigning a clinical significance class to individual variants following the ACMG clinical significance recommendations (Richards et al., 2015) . A subset of ClinVarʼs variations, nonsynonymous SNPs that change a single amino acid, closely reflects UniProtKBʼs "Natural variants", which include polymorphisms, variations between strains, isolates, or cultivars and disease-associated mutations (https://www.uniprot.org/help/variant) and are mostly (~98%) single amino acid changes. We evaluated UniProt Natural variant annotation against equivalent annotations in colocated ClinVar SNPs and found significant synergy between the two resources.
| METHODS
Mapping UniProtKB protein sequences to their genes and genomic coordinates are achieved with a four-phase Ensembl import and mapping pipeline. The mapping is currently conducted for the UniProt human reference proteome with the GRCh38 reference sequence and also for Saccharomyces cerevisiae S288C with the sacCer3 reference sequence. Reference sequences are provided by Ensembl. We summarize the approach here. Additional details, figures and references are provided in the Supporting Information Methods and Results document. 
|

| Phase two: Calculation of UniProt genomic coordinates
Given the UniProt to Ensembl mapping, UniProt imports the genomic coordinates of every gene and the exons within a gene. Included are the 3′-and 5′-UTR offsets in the translation and exon splice phasing.
With this collated coordinate data, UniProt calculates the portion of the protein sequence in each exon and defines the genomic coordinates for the amino acids at the beginning and end of each exon. This set of peptide fragments with exon identifiers and coordinates is stored as the basis for protein to genomic mappings in UniProt. 
| Phase four: UniProt BED and BigBed files
Converting protein functional information into its genomic equivalent requires standardized formats. The Browser Extensible Data (BED; UCSC, 2016a), a tab-delimited format, represents one format for displaying UniProtKB protein annotations on a genome browser.
The binary equivalent of the BED file is BigBed (Kent, Zweig, Barber, Hinrichs, & Karolchik, 2010) ; this format is more flexible in allowing additional data elements, providing a greater opportunity to fully represent protein annotations and is one of the file formats used to make track hubs. A track hub is a web-accessible directory of files that can be displayed in track hub-enabled genome browsers (Raney al., 2014) . Hubs are useful, as users only need the hub URL to load all the data into the genome browser. Moreover, a public registry for track hubs is now available (https://trackhubregistry.org/) allowing users to search for track hubs in one location and providing links to multiple genome browsers.
Using the protein genomic coordinates, with additional protein feature specific annotations from UniProtKB, the BED detail (UCSC, 2016b) and BigBed formatted files, as well as track hub required files, are produced for the UniProtKB human reference proteome.
Genomic coordinates are converted to the zero-based coordinates used within the BED file formats
| Mapping ClinVar SNPs to protein features and variants
The data for comparing ClinVar SNPs to UniProtKB features comes from the ClinVar variant_summary file from NCBI (ftp.ncbi.nlm.nih.-gov/pub/clinvar/tab_delimited/variant_summary.txt.gz), the UniProtKB feature specific BED files (ftp.uniprot.org/pub/databases/ uniprot/current_release/knowledgebase/genome_annotation_tracks/ UP000005640_9606_beds/) and the human variation file on the 
| Coverage
All Ensembl human proteome translations are mapped to locations on the genome. However, not all UniProt human proteins are mapped. Because we require 100% identity between the Ensembl and UniProt sequences, a relatively small number of well-annotated proteins in UniProtKB/Swiss-Prot are not mapped to the current genome (~5%). Some of these proteins are uncharacterized proteins, endogenous retrovirus proteins, and non-germline sequences related to cancer or the immune system, which could be considered a lesser priority. However, others are experimentally characterized proteins that use sequences that do not match the current consensus build. In some cases, the differences are small and can be addressed by curation or relaxing the match criteria. Other proteins such as mucin proteins encoded by the genes MUC2 and MUC19 are known to have variable repeat regions and the variation between the experimentally T A B L E 1 UniProtKB sequence annotations in track hubs. Annotation types, descriptions and current number of each feature mapped to the human genome are shown. UniProtKB release 2018_01 (Jan 2018) was used for this 
| Usage
The BED tab-delimited files are useful to extract genome locations and annotation for data integration and computational analysis similar to that described below for mapping to ClinVar SNPs.
However, we recommend using track hubs and not the BED text 
| Biological examples
To illustrate the utility of combining UniProt protein feature annotations and variation annotations to determine a probable mechanism of action, we looked at two well-studied disease- In these examples, we looked at the annotation of individual variants manually but, as we illustrate below, our alignment of genome and protein variant annotations can be applied to larger scale analyses. Table S1 ), indicating that the resulting disruption of protein structure is very likely to be harmful. The table shows there is general agreement among similar annotations between the databases, with 86% of UniProtKB disease-associated variants mapping to "pathogenic" SNPs in ClinVar and with 10% falling into the middle "Uncertain Significance" category. The remaining 4% fall mainly into the benign category. UniProtʼs "Polymorphism" category is closest in meaning to the "Benign" categories in ClinVar; here, again, there is 85% agreement. For the remaining 15% of "Polymorphism" variants 11% match the "Uncertain Significance" category in ClinVar, 3% are classified as "pathogenic" in ClinVar and 1% as "drug response." UniProtʼs "Unclassified" category is closest in meaning to ClinVarʼs "Uncertain Significance"; these are "gray" areas in each classification system and as such the agreement between the two databases is lowest: only 54% align and the rest are split between "pathogenic" and "benign" Pharmacogenomic variants may also be classified differently by protein curators and medical geneticists. Our colocated data set in Table 2 has 52 variations with a "drug response" annotation in ClinVar. Fourteen of these also have assertions of pathogenic, benign or uncertain, whereas 38 (0.6%) have only "drug response"
and were all "reviewed by an expert panel. on some antiviral drugs (Azakami et al., 2011; Chayama et al., 2011) . Whilst the annotations in the two resources is different, both are correct based on the publications cited and each groupʼs area of interest.
| Comparison of literature citations
Positional mappings also allow comparison of literature cited as evidence for the annotated assertions. We compared all PMIDs cited as evidence for the colocated ClinVar and UniProt variants (the same set that was used for Also, some ClinVar citations concern curation methods rather than the specific gene or variation. In UniProt, the missing PMIDs are an into a similar manner to "drug response" variants, because they confer sensitivity or resistance to a treatment regime (Boca, Panagiotou, Rao, McGarvey, & Madhavan, 2018; Li et al., 2017; Madhavan et al., 2018; Ritter et al., 2016) . Thus, the "pathogenic/ benign" terminology might not be appropriate for all cases.
The work described here provides the basis for a re-evaluation of UniProtKB annotation and the further standardization of this annotation with ClinVar and ClinGen. A detailed evaluation in which UniProt curators are performing a systematic re-curation of a randomly chosen set of variants from UniProt and ClinVar using the ACMG guidelines is being completed (M. Famiglietti et al., ) .
Recent efforts in the medical community to standardize the methods and levels of evidence required for the annotation of genetic variants (Amr et al., 2016; Manrai et al., 2016; O'Daniel et al., 2016; Richards et al., 2015; Walsh et al., 2016) , along with increasing amounts of population data (Amr et al., 2016; Walsh et al., 2016) , are leading to the widespread re-evaluation of previous assertions of pathogenicity. edu/cgi-bin/hgHubConnect?hubSearchTerms=uniprot) and the Ensembl genome browser (Aken et al., 2016; Hubbard et al., 2007) 
